BCHE and Lewy body dementia: While a similar proportion of patients were treated with cholinesterase inhibitors in both the DLB (73.6%) and AD (72.7%) groups (P = 0.272), N-methyl d-aspartate antagonists (15.0% vs. 9.9%), antidepressants (34.8% vs. 26.3%), antipsychotics (16.3% vs. 4.9%) and anxiolytics (13.3% vs. 8.2%) were significantly more often prescribed among the DLB group.